TY - JOUR
T1 - Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence.
AU - Corominas-Roso, Margarida
AU - Roncero, Carlos
AU - Eiroa-Orosa, Francisco Jose
AU - Gonzalvo, Begoña
AU - Grau-Lopez, Lara
AU - Ribases, Marta
AU - Rodriguez-Cintas, Laia
AU - Sánchez-Mora, Cristina
AU - Ramos-Quiroga, Josep-Antoni
AU - Casas, Miguel
PY - 2012/9/1
Y1 - 2012/9/1
N2 - Preclinical studies indicate that brain-derived neurotrophic factor (BDNF) is involved in neuroplastic changes underlying enduring cocaine-seeking following withdrawal. However, little is known about temporal changes in serum BDNF levels or the involvement of BDNF in craving and abstinence in early-abstinent cocaine-dependent patients. Twenty-three cocaine-dependent individuals (aged 33.65±6.85 years) completed a two-week detoxification program at an inpatient facility. Two serum samples were collected for each patient at baseline and at the end of the protocol. Serum samples were also collected for 46 healthy controls (aged 35.52±9.37 years). Demographic, consumption and clinical data were recorded for all patients. Significantly lower serum BDNF levels (p
AB - Preclinical studies indicate that brain-derived neurotrophic factor (BDNF) is involved in neuroplastic changes underlying enduring cocaine-seeking following withdrawal. However, little is known about temporal changes in serum BDNF levels or the involvement of BDNF in craving and abstinence in early-abstinent cocaine-dependent patients. Twenty-three cocaine-dependent individuals (aged 33.65±6.85 years) completed a two-week detoxification program at an inpatient facility. Two serum samples were collected for each patient at baseline and at the end of the protocol. Serum samples were also collected for 46 healthy controls (aged 35.52±9.37 years). Demographic, consumption and clinical data were recorded for all patients. Significantly lower serum BDNF levels (p
U2 - 10.1016/j.euroneuro.2012.08.016
DO - 10.1016/j.euroneuro.2012.08.016
M3 - Article
SN - 0924-977X
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
ER -